The Discounted Cash Flow (DCF) valuation of ImmunoGen Inc (IMGN) is (38.11) USD. With the latest stock price at 31.23 USD, the upside of ImmunoGen Inc based on DCF is -222.0%.
Based on the latest price of 31.23 USD and our DCF valuation, ImmunoGen Inc (IMGN) is a sell. selling IMGN stocks now will result in a potential gain of 222.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 9.4% | 7.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (127.05) - (22.26) | (38.11) |
| Upside | -506.8% - -171.3% | -222.0% |